20 results found.

Breast Cancer, or Neoplasm Metastasis Clinical Trial using Standard supportive care (packed RBC transfusion); epoetin alfa + packed RBC transfusion

Janssen Research & Development, LLC - Recruiting 18 years or older.
- A Randomized, Open-label, Multicenter, Phase 3 Study of Epoetin Alfa Plus Standard Supportive Care Versus Standard Supportive Care in Anemic Patients With Metastatic Breast Cancer Receiving Standard Chemotherapy.
Standard supportive care (packed RBC transfusion); epoetin alfa + packed RBC transfusion

Glioblastoma Multiforme, Squamous Cell Carcinoma of Head and Neck Clinical Trial using CC-115

Celgene Corporation - Recruiting 18 years or older.
- A Phase 1a/b, Multicenter, Open Label, Dose-Finding Study to Assess the Safety, Tolerability, Pharmacokinetics and Preliminary Efficacy of the Dual DNA-PK and TOR Kinase Inhibitor, CC-115, Administered Orally to Subjects With Advanced Solid Tumors, and Hematologic Malignancies..
CC-115

Breast Neoplasm, or Metastasis Clinical Trial using Eribulina

Medica Scientia Innovation Research - Recruiting 18 years or older.
- A Phase IIa Prospective, Multicenter, Open and Not Controlled of the Efficacy and Tolerability on the First Line Treatment With Eribulin as a Unic Agent on Patients With HER2 Negative Metastatic Breast Cancer Previously Treated With Taxanes.
Eribulina

Colorectal Cancer, Neoplasm Metastasis Clinical Trial using bevacizumab [Avastin]; 5-FU based doublet chemotherapy

Hoffmann-La Roche - Recruiting 18 years to 75 years.
- A Multi-center, Single-arm, Pilot Study of 5-FU Based Doublet Chemotherapy Plus Bevacizumab as Neoadjuvant Therapy for Patients With Previously Untreated Unresectable Liver-only Metastases From Colorectal Cancer.
bevacizumab [Avastin]; 5-FU based doublet chemotherapy

Neoplasms, Neoplasm Metastasis, or Lymphoma Clinical Trial using LY3039478

Eli Lilly and Company - Recruiting 18 years or older.
- A Phase 1 Study of LY3039478 in Patients With Advanced or Metastatic Cancer.
LY3039478

Neoplasms, Neoplasm Metastasis, Melanoma, Carcinoma, Non-Small-Ce Clinical Trial using LY3009120 capsule

Eli Lilly and Company - Recruiting 18 years or older.
- A Phase 1 Study of LY3009120 in Patients With Advanced or Metastatic Cancer.
LY3009120 capsule

Neoplasm Metastasis, Thyroid Neoplasm, or Thyroid Nodule Clinical Trial

National Institutes of Health Clinical Center (CC) - Recruiting N/A or older.
- Studies on Thyroid Nodules and Thyroid Cancer.

Carcinoma, Non-Small-Cell Lung, or Neoplasm Metastasis Clinical Trial using 34 Gy in a single fraction; 54Gy 18Gy/fr. x 3 fractions; 50Gy (12 x 5 fr.s); 60Gy (7.5Gy x 8fr.)

Institut Catal… d'Oncologia - Recruiting 18 years or older.
- Risk Adapted Free Flattering Filter Based Stereotactic Ablative Radiotherapy (Sabr) in Stage i Nsclc and Lung Metastases.
34 Gy in a single fraction; 54Gy 18Gy/fr. x 3 fractions; 50Gy (12 x 5 fr.s); 60Gy (7.5Gy x 8fr.)

Neoplasm Metastasis Clinical Trial using LY2940680

Eli Lilly and Company - Recruiting 20 years or older.
- A Phase 1 Study of LY2940680 in Japanese Patients With Advanced Solid Tumors.
LY2940680

Neoplasm Metastasis, or Lymphoma Clinical Trial using LY2835219

Eli Lilly and Company - Recruiting 20 years or older.
- A Phase 1 Study of LY2835219 in Japanese Patients With Advanced Cancer.
LY2835219

Head and Neck Neoplasms, Neoplasm Metastasis, Recurrent Disease, Clinical Trial using BKM120

Centre Leon Berard - Recruiting 18 years or older.
- A Phase II, Multicenter Trial Aiming to Evaluate the Clinical Interest of a Monotherapy With BKM120 , a PI3K Inhibitor in Patient With Metastatic Head and Neck Cancer Recurrent or Progressive Under Platin and Cetuximab-based Chemotherapy.
BKM120

Peutz-Jeghers Syndrome, Neoplastic Processes, or Neoplasm Metasta Clinical Trial using Everolimus

Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA) - Recruiting 18 years or older.
- Pilot Study of Everolimus in the Treatment of Neoplasms in Patients With Peutz-Jeghers Syndrome.
Everolimus

Neoplasm Metastasis Clinical Trial using Biopsy; Blood samples; Pharmacokinetics; Midazolam clearance test

UMC Utrecht - Recruiting 18 years or older.
- Feasibility Study of Biomarker Development for Response Prediction by Large Scale DNA Mutational Analysis of Metastatic Lesions.
Biopsy; Blood samples; Pharmacokinetics; Midazolam clearance test

Colorectal Neoplasms, Neoplasm Metastasis, or Liver Neoplasms Clinical Trial using Cetuximab; chemotherapy of mFOLFOX6 or FOLFIRI

Fudan University - Recruiting 18 years to 75 years.
- Study of Cetuximab in Combination With Chemotherapy for the First Treatment of Metastatic Colorectal Cancer.
Cetuximab; chemotherapy of mFOLFOX6 or FOLFIRI

Breast Neoplasms, Endocrine Breast Diseases, or Neoplasm Metastas Clinical Trial using letrozole; lapatinib; everolimus

University of Maryland - Recruiting 18 years or older.
- GCC 0901- A Phase II Study of Letrozole in Combination With Lapatinib Followed by an Addition of Everolimus in Postmenopausal Women With Advanced Endocrine Resistant Breast Cancer.
letrozole; lapatinib; everolimus

Breast Cancer, or Neoplasm Metastasis Clinical Trial using Non pegylated liposomal doxorubicin, trastuzumab, docetaxel

Catharina Ziekenhuis Eindhoven - Recruiting 18 years or older.
- Phase II Multicentre Open Label Study Evaluating the Efficacy and Safety of Liposomal Doxorubicin, Trastuzumab, Docetaxel as First-line Treatment of Patients With HER2 Positive Metastatic Breast Cancer.
Non pegylated liposomal doxorubicin, trastuzumab, docetaxel

Endometrial Neoplasms, or Neoplasm Metastasis Clinical Trial using Tumor biopsy study

University of Bergen - Recruiting N/A or older.
- Prospective Study of Endometrial Cancer Treatment in Relation to Molecular Markers in Curettage Specimens..
Tumor biopsy study

Breast Neoplasms, or Neoplasm Metastasis Clinical Trial

Beijing Cancer Hospital - Recruiting 18 years to 75 years.
- Gene Expression Profiling of Metastatic Breast Cancer Predict the Therapeutic Response to Chemotherapy.

Breast Neoplasms, Neoplasm Metastasis, Gene Expression Profiling, Clinical Trial using cytokine

Beijing Cancer Hospital - Recruiting 18 years to 75 years.
- Gene Expression Profiling of Breast Cancer Cells in Pleural Effusion Prodict the Response of Malignant Pleural Effusion to Immunotherapy.
cytokine

Brain Neoplasms, or Neoplasm Metastasis Clinical Trial using Whole brain radiation therapy arm; Salvage stereotactic radiosurgery arm

Japan Clinical Oncology Group - Recruiting 20 years to 79 years.
- Randomized Phase III Trial of Postoperative Whole Brain Radiation Therapy Compared With Salvage Stereotactic Radiosurgery in Patients With One to Four Brain Metastasis: Japan Clinical Oncology Group Study (JCOG 0504).
Whole brain radiation therapy arm; Salvage stereotactic radiosurgery arm